BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15919764)

  • 1. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
    Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
    J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
    Drapeau G; Audet R; Levesque L; Godin D; Marceau F
    J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-competitive pharmacological antagonism at the rabbit B(1) receptor.
    Larrivée JF; Gera L; Houle S; Bouthillier J; Bachvarov DR; Stewart JM; Marceau F
    Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins.
    Drapeau G; deBlois D; Marceau F
    J Pharmacol Exp Ther; 1991 Dec; 259(3):997-1003. PubMed ID: 1662280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
    Bawolak MT; Fortin JP; Vogel LK; Adam A; Marceau F
    Eur J Pharmacol; 2006 Dec; 551(1-3):108-11. PubMed ID: 17026984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.
    Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
    Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery.
    Pelorosso FG; Brodsky PT; Zold CL; Rothlin RP
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1355-60. PubMed ID: 15764737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor.
    Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1337-43. PubMed ID: 8667195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.
    Meini S; Lecci A; Cucchi P; Catalioto RM; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):137-43. PubMed ID: 9765332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of allelic polymorphism of the B(1) and B(2) receptor genes on the contractile responses of the human umbilical vein to kinins.
    Houle S; Landry M; Audet R; Bouthillier J; Bachvarov DR; Marceau F
    J Pharmacol Exp Ther; 2000 Jul; 294(1):45-51. PubMed ID: 10871294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial agonists and full antagonists at the human and murine bradykinin B1 receptors.
    MacNeil T; Feighner S; Hreniuk DL; Hess JF; Van der Ploeg LH
    Can J Physiol Pharmacol; 1997 Jun; 75(6):735-40. PubMed ID: 9276157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
    Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
    J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes.
    Gera L; Roy C; Bawolak MT; Charest-Morin X; Marceau F
    Peptides; 2012 Apr; 34(2):433-46. PubMed ID: 22349904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.